Skip to content

INGENIO 2 /INGEVITY MRI device family data collection in patients undergoing Magnetic Resonance Imaging

INGENIO 2 /INGEVITY MRI device family data collection in patients undergoing Magnetic Resonance Imaging

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON28451
Enrollment
20
Registered
2014-12-01
Start date
2015-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pacemakers, Magnetic Resonance Imaging, hartritmestoornis,bradyaritmie

Interventions

Subjects are enrolled when already implanted according to standard medical guidelines for pacemaker implantation and will undergo a Magnetic Resonance Imaging (MRI) scan under the labeled Conditions o

Sponsors

study sponsored by: Guidant Europe SA / NV, a Boston Scientific Company Clinical CRM Department Green Square Lambroekstraat 5D 1831 Diegem, Belgium
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Age 18 or above, or above legal age and willing and capable of giving informed consent specific to national law • Patients already implanted with ImageReady™ MR Conditional Pacing System, according to standard medical guidelines for pacemaker implantation. • Willing and capable of participation to the procedures indicated in the protocol.

Exclusion criteria

Exclusion criteria: • Patients implanted with other cardiac-related implanted devices or accessories other than the ImageReadyTM MR Conditional Pacing System • Low life expectancy (< 1 year) • Severe comorbidities that, according to clinical judgment, pose patient at risk to undergo MRI

Design outcomes

Primary

MeasureTime frame
The study is aimed at providing confirmatory data of no impact of MRI on device function, lead parameters and patient conditions for the CE-marked ImageReady™ MR Conditional Pacing System when used under the labeled Conditions of Use.

Contacts

Public ContactPhone: +39 348 2502687 Giovanni Raciti

E-mail: Giovanni.Raciti@bsci.com

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)